Back to Results

Rare CFTR Mutation Cell Collection Protocol (RARE)

Primary Objective

This is a non-interventional, multi-site, specimen collection study for CF patients who have rare CFTR mutations. Once a potentially eligible subject is identified (either self-identified or by their CF care center), and the subject has expressed interest in participating in the study, the subject will be referred to a participating study site to receive additional information about the study and about travel arrangements (if needed). Nasal epithelial cells and blood (to confirm genotype) will be collected from all subjects; additional blood samples and rectal biopsy samples will be optional. The study consists of a single visit, however it is anticipated that many subjects will need to travel so study participation time is estimated at 2 days.

Study

Is this Study for You?

Let's Get Started!

Details
Age

Child

Phase

Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.

Type of Study

Observational

Scope

National

Location

Childrens Hospital Colorado

Principal Investigator
Edith Zemanick,  MD

Edith Zemanick, MD

Study ID

Protocol Number: 16-2412

ClinicalTrials.gov: NCT03161808

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers